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*bje&e. The aim ofthis study Ins to datrrminc the tmg-‘Prm 
oulrolneand nwltivsriatr prfdictors Slate events in patients who 
underwent transventriadar mitral eammiwrotomy at the Mqo 
Clinic ia lbe early 19&k 
Back,pund. Percutaomus ballann mitral valvulaplasty is a” 
bnpartard new prwedure for which loo@erm follow-up data are 
““t yet available. However, rwh data do exist for patients who 
bavr undergone bansverdriadax nitrat rammkwrotorny, asim- 
Uar bd dder aad ewe invnsivr prwedore. 
Metlwds. Follow-up data @watt duraiion 13.9 years) ior 107 
mkswtomy were obtained from medid recwds. referring p&y. 
stctaq questimtirer awJ telephone interviews. Survival and 
survival free al repeat canmbwatamy or mitral valve surgery 
were estl(ilapted with the Kaplan-M&r method. Cox propartio”al 
hnrds m&l was lied to detentdoe predictan “f ~rvlval ar,d 
repeat mltral valve surgery. 
Rem&s. Postap~tively, 92% of patients had symptomatic 
Percutaneous balloon mitral valvuloplasty is emerging as 
an attractive therapeutic alternative to operative com- 
missurotcmy in selected patients with symptomatic mitral 
stenosis (I-6). As experience with percutaneous balloun 
mitral valvulaplasty has accrued, important inforomtion 
regarding procedural technique (7.8). patient selection 
criteria (9.10). immediate res:dts (4.1 t .l2) and immediate 
complications (K-15) has become available. However, 
because this procedure has been introduced relatively re- 
cently, only- short-term follow-up data are available 
(3.4,8,16). ‘The longest follow-up ofany published report was 
27 months (5). 
Nevenheless. as is true of any invasive procedure, illl 
estimation of the potential for long-term clinical improve- 
ment is crucial in the clink-~1 decision-ma!& process and is 
necessary to determine the ultimate value of percutaneous 
balloon mitral valv”loplasty. We believe that follow-up data 
from paticna undergoing tliinsveniric”lar miirat valve coin- 
missumtomy may be a useful surrogate far percutaoeuus 
balloon mitral valvuloplasty because of the technical eiml- 
larities !wtween the two procedures. Both procedures in- 
volve “envisually directed dilation of the stenotic mitral 
valve orifice: in percutaneous balloat mitral valvuloplasty, 
balloons are placed under Ruoroscopic contml and then 
inflated. whereasin tmnsventricularmitral valve commiisur- 
otomy the dilator is positioned and opened after traosven- 
tricular pbwment. The eiTlcacy of both prwedores depends 
on adeqoze :ommissural splitting (17.18;. Patients likely to 
benefit from eitlwr procedure ax relatively young with 
mobile, relatively noncalcified leatlets and IiItle subvaivular 
fusion ll9.20). Although percutaneous balloon mitral v&o- 
loplarty is a relaively new invasive recbqae, transve&~- 
ular mitral valve commissuroiamy is a matwe surgical 
procedure with >30 years of experience in its uss (21-261. 
Here. we repon locg-term rescltn (mean follow-up interval 
13.9 years) of 267 patients who underwG closed transven- 
iricular mitral commissurotomy at the Mayo Clinic. 
Methods 
Subjects. From 1960 to I!& 267 pataenis with a mean 
age of 43.6 yews irxge 14 to 691 underwent transventricular 
mitral conmussurolomy at the Mayo Clinic. The immediate 
results and complications for this series were reported 
previously (21). All patients with severe. symptomatic mitral 
stenosis were considered for commissuroiomy. but those 
with heavily calcified. immobile valves, significant mitral 
regurgitation or muitiva;vuldr disease were thought to be 
better suited for valve replacement and were excluded. A 
previous commissurotomy or history of an embolic phenom- 
enon was not considered a iontramdication to the procedure 
(21). Only 9% of patients underwel.. preoperative diagnostic 
cardiac cslheterization because this procedure was noi rou- 
finely performed at the time OUT patients underwent opera- 
tion. Our study was conducted with the apprwxd of the 
Clinical Practice Committee of Cardiovascular Diseases and 
Internal Medicine at the Mayo Clinic. 
Operative iechniqw. Transveniricular mitral valve com- 
missurotomy was performed, as described previowly (181. 
through a left lateral thoracoromy. The left atrial appendage 
was opened and the right index finger was positioned ai the 
inlet of the mitral valve. allowing palpation of the fused 
leaflets. A transventricular dilalor was advanced through an 
apical ventriculalomy to the mitral valve orifice. The dilator 
was then positioned across the mitral valve orifice by palpa- 
tion and opened one to four times. 
Data collection and analysis. Information collected from 
the medical records included baseline demogaphic data. 
elecimcardiographic (ECG) and roenigenographic results. 
and the findings, ~sults and complications of the operations. 
Follow-up data were obtained from medical records and by 
contact with referring physicians, questionnaire and. if nec- 
essary, telephone. The specific follow-up data recorded 
included vital states. cause of deaib, symptom status, need 
‘-I repeat dilation or mitral valve iaplaccment and occw- 
rence of stroke. The mean follow-up interval was 13.9 years 
(range 0 to 34.7). with 98 patients under observation at 20 
years. 
Survival and survival free of repeat commissurotomy or 
miira! velve su~ery were estimated as a function of time 
from initial dilation by using the Kaplan-Meier product limit 
method. Life-table probability of survival is presented as 
percent ? SE. Predictors of survival and repeat mitral valve 
surgery were determined by Cox pruporiional hazards anal- 
ysis with the use of bmh univariate and multiwiate nodels. 
Patients with mitral anu!us calcification or with left atrial 
rnmmhi were identified. and the remainder we:e analyzed as 
a separate subgroup to approximate better the patient pop 
ulation currently considered suitable for percutaneous bal- 
loon mitral vnlvuloplasry. 
Resu!ts 
Baseline chplacieristier. Of the 267 patients studied, 207 
(78%) were female and 60 (22%) were male (Tabi: I). The 
mean age at operation was 43.6 yezs. Ninety-six percent of 
patients had dyspnea, which in 61% was functional siass ii: 
or IV according to the New York Heart Association classi- 
fication. There was a history of transient iscbemic attack or 
stroke in 14% of patients. Peripheral embolism had occurred 
in I I%. and mild mitral regurgitation, it.e most commonly 
associated cardiac abnormality, was present in 19.5%. 
There was atrial fibrillation in S4% of patients and ECG 
evidence of right ventricular hypertrophy in 34%. Chest 
roentgenography and Ruoroscopy documented left atrial 
enlargement in 90% of patients and calcification of the mitral 
vatve in 20%. 
On the basis of the medical history, physical findings and 
test results, the degree of mitral stenosis was thought to be 
severe in 19.8% of patients, moderate in 14.6% and ;nild in 
Z 6%. 
Sulqlcal Wings and lale outcome. A left atrial thrombus 
was identified in 24% of patients at operation. At 30 days 
postoperatively, 2.6% of pdiienis had died, I.% had had 
strokes and 1.1% had sustained B peripheral thromboembo. 
lism. Postoperatively. 32% of patients had relief from car 
disc symptoms. This improvement lasted from I to 2 ye.w 
for l2:l% of patients, from 3 to 4 wars for 24.4%. from 5 to 
IO years for iS.S% and from IO to 20 yew fcr?4.4% (Fig. I). 
Thus. symptomatic improvement was sustained for a3 to 4 
years in 78% of our patienrs. 
Long-term ~sults for our patients are depicted in Figure 
2. The probabiiiry of survival was 79 + 2.7%. 66.8 z 3% 
and 55.3 ? 3.5% ttt IO, IS and 20 years. respectively. Most 
(74%) ofthe deaths that occurred during the follow-up period 
were due to cardiovascular causes. In 33% of cases. death 
was related to complications of mival valve disease and in 
13% to acute myocxdial infarction. The other cardiovascu- 
lar causes of d&h included sudden death (9%) and stroke 
(6%). 
An increasing number of patients required mitral valve 
replacement during the follow-up period. At 5 years. 8.9% of 
FIgwe 2. Top, KaplawMeier life-table probability of survival of rbe 
study subjects Wavy tine, by number of years after tranrventricular 
mitral commhsumtomy compared with that for age- md gender- 
ma’?hed wnttol subjects (thin line) (p < O.&WI). B&tom. Kaplan. 
I! ‘x fife table for survival and survival free of repeat mitral valve 
op. .-lion by number of yeam after initial closed transventncular 
ccmmu~ mtomy. Numbers in parentheses refer to the number of 
patients xder observation. Ermr bars represent 2 SE. 
the panems had undergone mttral va!vc replacement. and at 
IO yran. 25%. Repeat mttral valve ddatwn was also per- 
formed wth maeasing frequency: by IO years, 34% uf all 
pauents bad required either rrpeat surgical commtssurotony 
or mitral valve replacement. 
The probabdity of being alive and free of repeat mitral 
va!x opertisn L 5 ?EXj. *as 83.C I 2.5%. at IO ye*,3 wa, 
56.7 2 3.4% and at 20 years was 24.4 + 3.1% (Fig. 2). After 
imtial commi~surotomy, mo=~ patients did not rxpcrieoce 
any transient or Axed cerebrovascular event. At 10 years. 
90% of p&nts were free of any such event. and 46% were 
taking coumadm at the time of their last evaluation. 
Subgroup analysis. Currently at the Mayo Clinic. all 
patients under consideration for percutaneousballoon mitral 
vslvuloplasty undergo tmnsesophageal echocardiogaphic 
examination so that those with left atrial thrombi can be 
excluded (27). Also, dense calcification of the mitral valve 
and anulus decreases the likelihwd of a successful, uncom- 
plicated immediate result (9,IO,28) and may be a contraindi- 
cation to the procedure. Therefore. to approximate better 
the patient population currently undergoing percmatteous 
balloon mitral valvuloplasty. patients with calcification of 
the mitral valve seen on chest roentgenognphy or !ef! at+! 
thrombt found at operation were identified (gmup 2. a = 
103). and the remaining I64 patients were snatyzzd as t. 
separate rubgroup (group I,. 
Generally. the long-term results of group 1 were superior 
(Fig. 3): life-table probabilities rf survival were 84.2 + 3.0% 
at IO ycar~ and 63.4 i 4.4% at 20 years.. These values are in 
contrast to life.tahle probabilities of survival of70.3 t 5.U% 
at IO years and 41.9 + 5.7% at 20 years for grcily 2 patients 
(D = O.CW2t. The life-table mobabilitv >f freedom from . , 
death x repeat mitral valv.: operation was also significantly 
better: it ~a, 84.9 2 2.9% at 5 years and 65.4 f 4.1% at IO 
years forgroup I and 12.2 2 4.h%a:5 yearsand42.3 L 5.5% 
at 10 pears for group 2 (p < O.cJxQI). 
Ptwliclors of ott*,wm. The results of cox prowxtional 
hazards analyses of survival and survival free if repeat 
mitral vaive surgery are g&t in Tables 2 and 3, respx- 
tively. Many variables (the baseline characteristics outlined 
in Table 1 DIUS concomitant valvular lesions) were exattined 
by using both univatiate and multivatiate models. 
Two of three i&dependent predictors of survival (age and 
male gender) \xere of a general rather titan a cardiovascular 
nature. However. the rmence of atrial fibrillation. perhaps 
reprcsenliog more &anced heart disease, was alfo in&- 
pendently associated with a greater ha;ud ratio of dying in 
long-tern, follow-up. Cxdiomegaly. rr.itral valve calcitica- 
!ion CT left atrid thmmbi were univariate predictors ofdeath, 
whereas concomitant mitral regurgitation faded to reach 
xattzticzl sI:niF.culce z! !k: 0.95 level. 
On the other band. anatomic and phyriologtc character- 
istics of mitml valve disease proved tb be me important 
univariate ana multivariate predictors of freedom from re- 
peat ,mitral valve surgery. Not unexpectedly, mitral valve 
calcdication a2d concom!tant m;:rz! regurgitation were two 
of these predic!ors. Cardiomegaly, again perhaps nflecting 
more advanc-.d heart disease. was also independently .wo- 
cAted with higher hazard raoz. 
The multivariate proponianal hazards modeis were also 
used fo gain further perspective on potential long-term 
outcomes after trassieiltriciilai mirral commissurotomy: 
the pwdicred long-ferm pwxnt survival and predicrrd 
percent freedom from repeat mitral valve surgery for pa 
tients in Ihe risk ca@wies defined by our multivariate 
mcdels were calculated and are displayed in Tables 4 and 
5, respectively. For example, a SQyear old woman wi’:l 
symptomaric mirral stenosis, in normal sinus rhythm and 
wthout significant mhrai zdciiication, mitral rcgurghatiora 
or cardio&galy would have an 85.4% chance of living 
IO wars and an 84.5% chance of nvoidinz rerxat mitral 
Discussion 
The current series. On the basis of long-lerm follow-up 
Wean duralion 13.9 years), our study documents a favorable 
outcome for the majority of the 267 pa&n& who underwent 
closed transventricular mitral commissuiotomy. Late sur- 
vival was excellent, with the Kaplan-Meier iife-table proba- 
bility of survival of 94%. 90% and 79(7r at I, 5 and IO years. 
respectively. Ninety-two percent of all the pauenls expen- 
enced symptomatic relief after commissurommy. and for 
78% of these patients, this relief was sustained at tewt 3 
years. 
As expected, mitral valve replacement or repeat commis- 
surotomy was necessary with increasing frequency as the 
number of years of follow-up increased. Nonetheless. at the 
end of to years, 57% of the patients were alive and had not 
required another surgical procedure. Despite the prevalence 
of left atria1 thrombi at operation. the perioperative and 
long-term rates for stroke after hansventricular mitral corn- 
missurotomy were very low in our series. 
Our study also documented the independent predxtors of 
ootc ae after transventricular mitral commissurolomy. An- 
atomic factors such as mitral valve calcification and the 
preseocc of mitral regurgitation significantly increased the 
likelihood of requiring future surgical intervention. These 
results are consistent with those of other investigator: 
(22.231 and with the short.term results of oercutaneous 
b&i mitral valvuloplasty (17). 
In summary, closed transvcntricular mitral commissur- 
ctomy as pSx!ned by su:&eoas at the Mayo Clinic from 
19M1 IO 1964 provided excellent long-term palliation for 
patients with symptomatic mitral stenosis nod should be 
considered in selected patient+especially in countries 
where cardiopulmonary bypass is not readily available. 
Implications b prculan~s b&on mitral valwhplasty. 
We believe oar data provide a perspective on poteniial 
long-ten o”,comes after percutaneous baltwn mitral val- 
vutoplssty, a procedure for which long-term data are not 
available. If patients with either cdcification of the miti 
v&e or left atriat thrombi in th. wwni series were ex- 
cluded from analysis, the observed long-term outcome was 
better, with 65% of patients being both alive and free of 
repeat mittal valve operation at 13 years. Such a dts:jnction 
is important because pat’-nlr without these unfavorable 
chz~~ccrertstics belter approximate those undergoing txcu- 
taneous balloon mitral vrdwloptarty. 
Although there are obvious differences in technique. 
percutaneous balloon mitral valvulopiasty and traosventric- 
ular mitral valw com~irsurotomy both involve nonvisua!ly 
direcred dilatton oflhe mitral valve apparatus: for the former 
procedure. dilaiion is achieved with Auoroscopic guidance. 
and for the latter. the vatvutotome is placed usins palpation. 
With both prucedurer. sufficient pressure is often exerted to 
separate both the anterolateral and the posteromedial com- 
missures l17.18.21.25). 
The patient p+pttlation currently considered soltable for 
percutaneous balloon mitral valvuloplasty is very similar to 
the pat!eni group repned here: relatively young patients 
with symptomatic mitral steoasis but with little regurdta- 
tion. with an opening snap and pliable and minimally calci- 
fied or fused leaffets. 
We speculate that given ihe simdarities in patlent papa- 
lation. mechanism of dilation. symptomatic resolts (21.27) 
ar.J perioperative complication rates, the long-term results 
reported herein can be used to predict the oo!come of 
&ems undergoing percutaneous balloon mitral vatvulo- 
plasty. tiowever. our data do not indicate which procedure 
is to be preferred nor do they consider open mitral commis- 
surotomy. which is the preferred surgical procedure in many 
developed nations (29.30). The initial results of randomized 
trials (31.32) indicate that both percutaneous and transven- 
tricutar approaches to mitrat valve dilation are stiz and 
result in roughly equal hemodynamic and symptamaiic im- 
provement. The ultimate acceptance of percutaneous bal- 
loon mitral valvuloplasty as standard treatment for sympio 
matic mitral stenosis will depend on the demonstration of 
continued long-term efficacy and safety. 
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